URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Robert Holloway

Concepts (521)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Stroke
23
2000
134
7.940
Why?
Parkinson Disease
35
1998
394
5.890
Why?
Neurology
14
1996
82
3.740
Why?
Antiparkinson Agents
11
1998
110
2.640
Why?
Decision Making
7
2005
220
2.580
Why?
Cost-Benefit Analysis
22
1996
200
2.420
Why?
Thiazoles
9
1998
85
2.350
Why?
Health Care Costs
10
1996
99
2.180
Why?
Terminal Care
4
2007
69
2.160
Why?
Humans
127
1995
35000
2.140
Why?
Evidence-Based Medicine
8
1999
197
2.080
Why?
Quality-Adjusted Life Years
14
1997
50
2.050
Why?
Withholding Treatment
3
2005
40
2.000
Why?
Palliative Care
7
2007
151
1.900
Why?
Levodopa
9
2000
112
1.840
Why?
Patient Preference
3
2011
9
1.800
Why?
Biomedical Research
7
2003
132
1.690
Why?
Quality of Life
14
2000
486
1.630
Why?
Nervous System Diseases
5
1998
141
1.610
Why?
Research Design
7
2004
326
1.600
Why?
Medical Errors
5
2001
35
1.450
Why?
Cyclohexanecarboxylic Acids
4
2005
47
1.340
Why?
Amines
4
2005
64
1.330
Why?
Treatment Outcome
23
1998
2487
1.330
Why?
Middle Aged
46
1996
9461
1.310
Why?
gamma-Aminobutyric Acid
4
2005
90
1.300
Why?
Brain Ischemia
7
1996
79
1.230
Why?
Analgesics
3
2007
108
1.220
Why?
Hospitals
4
2001
60
1.200
Why?
Antidepressive Agents, Tricyclic
2
2007
30
1.160
Why?
Drug Industry
5
2006
28
1.150
Why?
Academic Medical Centers
4
1996
93
1.140
Why?
Aged
36
1996
6986
1.120
Why?
Multiple Sclerosis
3
1997
125
1.100
Why?
Epilepsy
4
2005
118
1.090
Why?
Patient Participation
3
2009
71
1.090
Why?
Clinical Trials as Topic
8
2000
664
1.090
Why?
United States
22
1998
2511
1.070
Why?
Ischemic Attack, Transient
3
1996
40
1.030
Why?
Referral and Consultation
5
1999
188
1.030
Why?
Interferon-beta
4
2001
60
1.010
Why?
Antibodies, Monoclonal
3
2007
725
1.000
Why?
Female
53
1996
19061
0.980
Why?
Radiopharmaceuticals
3
2000
48
0.970
Why?
Practice Guidelines as Topic
5
1999
288
0.940
Why?
Questionnaires
10
2002
942
0.940
Why?
Models, Economic
4
2001
27
0.940
Why?
Delivery of Health Care
3
2008
136
0.940
Why?
Membrane Transport Proteins
3
2000
63
0.910
Why?
Aged, 80 and over
18
2001
2423
0.910
Why?
Randomized Controlled Trials as Topic
8
2001
400
0.910
Why?
Quality Assurance, Health Care
4
1998
114
0.900
Why?
Decision Support Techniques
5
1996
70
0.900
Why?
Male
49
1996
18870
0.890
Why?
Conflict of Interest
3
2005
35
0.890
Why?
Professional-Family Relations
2
2010
59
0.870
Why?
Cerebrovascular Disorders
3
1996
111
0.860
Why?
Myositis, Inclusion Body
2
2001
25
0.850
Why?
Parkinsonian Disorders
3
2000
26
0.850
Why?
Health Status Indicators
2
2010
97
0.840
Why?
Cocaine
3
2000
78
0.840
Why?
Life Support Care
2
2011
24
0.830
Why?
Disclosure
2
2008
34
0.800
Why?
Dopamine
3
2000
192
0.800
Why?
Patient Care
1
2012
34
0.790
Why?
Benzothiazoles
11
1998
54
0.790
Why?
Dopamine Agonists
4
2000
29
0.780
Why?
Advance Directives
1
2011
20
0.780
Why?
Corpus Striatum
2
2000
151
0.780
Why?
Membrane Glycoproteins
4
1989
350
0.770
Why?
Hospitalization
3
2010
354
0.760
Why?
Dopamine Agents
2
2000
31
0.760
Why?
Medicare
4
2006
126
0.750
Why?
Magnetic Resonance Angiography
1
2011
35
0.730
Why?
Immunologic Factors
2
2007
69
0.720
Why?
Desipramine
2
2007
35
0.720
Why?
Craniotomy
1
2010
16
0.720
Why?
Infarction, Middle Cerebral Artery
1
2010
16
0.710
Why?
Tracheostomy
1
2010
19
0.700
Why?
Pleurodesis
1
2010
4
0.700
Why?
Talc
1
2010
5
0.690
Why?
Pleural Effusion, Malignant
1
2010
10
0.690
Why?
Diffusion Magnetic Resonance Imaging
2
2007
64
0.690
Why?
Carotid Arteries
1
2011
96
0.690
Why?
Tomography, Emission-Computed, Single-Photon
5
2000
65
0.690
Why?
Time Factors
7
2005
3047
0.690
Why?
Dementia
5
1999
91
0.680
Why?
Drugs, Generic
1
2009
7
0.670
Why?
Hospital Mortality
4
2007
131
0.670
Why?
Drug Costs
1
2009
22
0.660
Why?
Catheters, Indwelling
1
2010
69
0.660
Why?
Placebos
5
2001
177
0.660
Why?
Selegiline
1
2009
69
0.650
Why?
Adult
28
1996
10906
0.650
Why?
Brain Injuries
1
2010
91
0.630
Why?
Diagnostic Errors
2
2005
87
0.630
Why?
Prognosis
6
1995
1030
0.610
Why?
Societies, Medical
2
2008
132
0.610
Why?
Economics, Pharmaceutical
1
2008
7
0.600
Why?
Benchmarking
2
2005
44
0.600
Why?
Endarterectomy, Carotid
3
1998
30
0.590
Why?
Health Services Accessibility
1
2009
152
0.590
Why?
Anticonvulsants
2
2005
96
0.580
Why?
Diabetic Neuropathies
1
2008
39
0.580
Why?
Mortality
2
2005
87
0.580
Why?
Internet
1
2008
92
0.580
Why?
Central Nervous System
1
2008
110
0.570
Why?
Iatrogenic Disease
1
2007
27
0.570
Why?
Central Nervous System Diseases
2
1997
58
0.570
Why?
Neuralgia, Postherpetic
1
2007
26
0.560
Why?
Choice Behavior
1
2007
44
0.550
Why?
Diagnostic Techniques and Procedures
1
2006
11
0.550
Why?
Health Services Research
2
2003
104
0.550
Why?
Nerve Tissue Proteins
3
2000
310
0.540
Why?
Biological Markers
4
2002
532
0.540
Why?
Patient Satisfaction
2
2007
216
0.540
Why?
Double-Blind Method
10
2000
985
0.540
Why?
Health Status
3
2004
263
0.540
Why?
Brain
4
1996
1161
0.530
Why?
Diagnostic Tests, Routine
1
2006
47
0.530
Why?
Reflex, Babinski
1
2005
1
0.520
Why?
Publishing
1
2006
45
0.520
Why?
Length of Stay
5
1998
284
0.520
Why?
Malpractice
2
2001
17
0.520
Why?
Antiemetics
2
2005
55
0.520
Why?
Sleep Apnea, Obstructive
1
2005
17
0.500
Why?
Scopolamine Hydrobromide
1
2005
11
0.500
Why?
Cranial Fossa, Posterior
1
2005
8
0.500
Why?
Quality Indicators, Health Care
2
2001
54
0.490
Why?
Periodicals as Topic
1
2006
77
0.490
Why?
Antipsychotic Agents
1
2006
96
0.480
Why?
Severity of Illness Index
7
2001
878
0.480
Why?
Outcome Assessment (Health Care)
6
2001
275
0.470
Why?
Substantia Nigra
1
2005
73
0.470
Why?
Vomiting
1
2005
114
0.460
Why?
HIV Infections
3
1996
600
0.460
Why?
New York
8
1999
1191
0.460
Why?
Acquired Immunodeficiency Syndrome
2
1995
207
0.450
Why?
Neurosurgical Procedures
4
2005
29
0.450
Why?
Hospital Departments
1
2003
17
0.450
Why?
Research
2
1998
169
0.440
Why?
Risk Management
1
2003
18
0.440
Why?
Physician's Practice Patterns
3
1999
223
0.440
Why?
HIV-1
3
1995
544
0.440
Why?
Education, Medical, Undergraduate
1
2004
91
0.430
Why?
Mass Screening
1
2005
223
0.420
Why?
Patient Selection
2
2003
197
0.420
Why?
Carrier Proteins
2
2000
410
0.410
Why?
Antidepressive Agents
1
2003
88
0.410
Why?
Research Subjects
3
2008
16
0.410
Why?
Proportional Hazards Models
5
2000
398
0.400
Why?
Outcome and Process Assessment (Health Care)
2
2001
74
0.400
Why?
Anticoagulants
2
2000
128
0.400
Why?
Magnetic Resonance Imaging
5
1996
928
0.400
Why?
Disability Evaluation
5
2007
125
0.390
Why?
Electric Stimulation Therapy
1
2001
29
0.380
Why?
Health Care Rationing
1
2000
8
0.370
Why?
Adjuvants, Immunologic
1
2001
118
0.360
Why?
Communication
3
2005
245
0.360
Why?
Reproducibility of Results
8
2003
859
0.360
Why?
Critical Pathways
1
2000
5
0.360
Why?
Risk Assessment
7
2005
808
0.350
Why?
Quality of Health Care
3
2007
187
0.350
Why?
Decision Trees
4
1996
27
0.350
Why?
G(M1) Ganglioside
1
1999
6
0.350
Why?
Depressive Disorder
1
2003
307
0.350
Why?
Autoimmune Diseases of the Nervous System
1
1999
6
0.350
Why?
Motor Neuron Disease
1
1999
6
0.350
Why?
Education, Medical, Continuing
2
1999
65
0.340
Why?
Fibrinolytic Agents
3
2001
59
0.340
Why?
Sensitivity and Specificity
8
1996
866
0.340
Why?
Research Support as Topic
3
2006
51
0.330
Why?
Aorta, Thoracic
1
2000
72
0.330
Why?
Multiple Sclerosis, Relapsing-Remitting
2
2007
22
0.330
Why?
Physicians
1
2001
143
0.330
Why?
Antibodies, Monoclonal, Humanized
3
2007
89
0.330
Why?
Markov Chains
4
1999
40
0.330
Why?
Autoantibodies
1
1999
109
0.330
Why?
Safety Management
3
2004
26
0.320
Why?
Medication Errors
3
2003
17
0.320
Why?
Young Adult
4
2009
1013
0.320
Why?
Brachial Plexus
1
1998
3
0.320
Why?
Hypertension, Pulmonary
1
1999
28
0.310
Why?
Clavicle
1
1998
19
0.310
Why?
Retrospective Studies
8
1998
2167
0.310
Why?
Iodine Radioisotopes
3
2000
98
0.310
Why?
Gene Transfer Techniques
3
2006
145
0.310
Why?
Enzyme-Linked Immunosorbent Assay
1
1999
459
0.300
Why?
Inpatients
2
1996
69
0.300
Why?
Thrombosis
1
2000
196
0.300
Why?
Migraine Disorders
2
2006
19
0.300
Why?
Fractures, Bone
1
1998
85
0.300
Why?
Attitude of Health Personnel
1
2000
267
0.300
Why?
Data Collection
4
1999
201
0.300
Why?
Carotid Stenosis
2
2005
48
0.290
Why?
Clinical Protocols
1
1998
102
0.290
Why?
Anti-HIV Agents
1
1999
179
0.290
Why?
Attitude to Health
3
2003
198
0.290
Why?
Biopsy
2
1996
359
0.280
Why?
Pilot Projects
5
2001
426
0.280
Why?
Comorbidity
3
1998
365
0.280
Why?
Cross-Sectional Studies
3
2003
627
0.280
Why?
Great Britain
3
2002
95
0.280
Why?
Cost of Illness
3
2004
73
0.270
Why?
Toxoplasmosis, Cerebral
1
1996
5
0.270
Why?
Costs and Cost Analysis
1
1996
84
0.270
Why?
Ethics Committees, Research
2
2003
17
0.260
Why?
Cerebral Hemorrhage
2
1996
56
0.260
Why?
Cohort Studies
5
2007
912
0.260
Why?
Observer Variation
3
2000
137
0.260
Why?
Headache
1
1995
46
0.250
Why?
Forecasting
2
2005
172
0.250
Why?
Adolescent
5
1996
4513
0.250
Why?
Disease Progression
3
2002
496
0.250
Why?
Guideline Adherence
2
1999
72
0.250
Why?
International Classification of Diseases
2
2007
15
0.240
Why?
Tomography, X-Ray Computed
4
1997
729
0.240
Why?
Cause of Death
2
2011
155
0.240
Why?
Dopamine Plasma Membrane Transport Proteins
3
2000
32
0.240
Why?
Sickness Impact Profile
2
2002
35
0.230
Why?
Predictive Value of Tests
5
1999
579
0.220
Why?
Thrombolytic Therapy
2
2009
65
0.220
Why?
Age Factors
2
1996
1060
0.220
Why?
Life Support Systems
1
2012
3
0.210
Why?
Advance Directive Adherence
1
2012
3
0.210
Why?
Cardiopulmonary Resuscitation
1
2012
24
0.210
Why?
Accidental Falls
2
2007
47
0.210
Why?
Risk Factors
5
2000
2172
0.210
Why?
Financing, Government
2
2009
24
0.210
Why?
Diagnostic Imaging
3
1999
81
0.200
Why?
Intensive Care Units
2
1998
106
0.200
Why?
Endometrial Neoplasms
1
2012
36
0.200
Why?
Tissue Plasminogen Activator
1
2012
50
0.200
Why?
Patient Care Team
2
2000
189
0.200
Why?
American Heart Association
2
2008
22
0.200
Why?
Government Agencies
2
2008
13
0.200
Why?
Drug Approval
2
2006
19
0.200
Why?
Neurosurgery
1
2012
6
0.200
Why?
Odds Ratio
2
2010
301
0.200
Why?
National Institutes of Health (U.S.)
2
2006
60
0.200
Why?
Plasma Exchange
1
2011
16
0.200
Why?
Enteral Nutrition
1
2011
34
0.200
Why?
Genital Neoplasms, Female
1
2011
33
0.200
Why?
Recurrence
3
2007
656
0.200
Why?
Narration
1
2011
20
0.200
Why?
Endpoint Determination
1
2011
31
0.200
Why?
Albuterol
1
2001
26
0.200
Why?
Gynecologic Surgical Procedures
1
2011
13
0.190
Why?
Immunoglobulins, Intravenous
1
2011
38
0.190
Why?
Truth Disclosure
1
2011
22
0.190
Why?
Adrenergic beta-Agonists
1
2001
52
0.190
Why?
Leukoencephalopathy, Progressive Multifocal
2
2007
16
0.190
Why?
Muscular Dystrophy, Facioscapulohumeral
1
2001
24
0.190
Why?
Hospital Costs
1
2011
32
0.190
Why?
Patient Protection and Affordable Care Act
1
2011
5
0.190
Why?
Time
2
2007
44
0.190
Why?
Drug Therapy, Combination
2
1999
375
0.190
Why?
Myasthenia Gravis
1
2011
62
0.190
Why?
Hospitals, Special
1
2011
7
0.190
Why?
Family
1
2012
198
0.180
Why?
Celiac Disease
1
2010
19
0.180
Why?
Robotics
1
2011
76
0.180
Why?
Endoscopy, Gastrointestinal
1
2010
24
0.180
Why?
Patient Acceptance of Health Care
2
2008
100
0.180
Why?
Angioplasty
1
2010
31
0.180
Why?
Reimbursement, Incentive
1
2010
10
0.180
Why?
Physician's Role
1
2011
119
0.180
Why?
Health Services Needs and Demand
1
2011
93
0.170
Why?
Health Facilities
1
2009
6
0.170
Why?
Curriculum
2
1999
229
0.170
Why?
Hospitals, Veterans
1
2009
16
0.170
Why?
Therapeutic Misconception
1
2009
3
0.170
Why?
Immunosuppressive Agents
1
2011
200
0.170
Why?
Geriatric Assessment
1
2011
158
0.170
Why?
United States Department of Veterans Affairs
1
2009
23
0.170
Why?
Prescriptions
1
2009
6
0.170
Why?
Ethics, Research
2
2005
16
0.170
Why?
Drug and Narcotic Control
1
2009
10
0.170
Why?
Acute Disease
3
2001
570
0.170
Why?
Postoperative Complications
3
1998
706
0.170
Why?
Disease
1
2009
36
0.170
Why?
Hot Flashes
1
2009
28
0.170
Why?
Neurologic Examination
2
2005
143
0.160
Why?
Sleep
1
2009
56
0.160
Why?
Medicaid
2
2006
82
0.160
Why?
European Continental Ancestry Group
1
2011
225
0.160
Why?
Coronary Artery Disease
1
2010
85
0.160
Why?
Managed Care Programs
2
1999
81
0.160
Why?
United States Dept. of Health and Human Services
1
2008
3
0.160
Why?
Health Services
2
2006
59
0.160
Why?
Women's Health
1
2009
58
0.160
Why?
Health Expenditures
2
2005
38
0.160
Why?
Consent Forms
1
2008
4
0.160
Why?
Clinical Trials, Phase I as Topic
1
2008
11
0.160
Why?
Fees and Charges
1
2008
12
0.160
Why?
African Americans
1
2011
209
0.160
Why?
Financial Support
1
2008
5
0.160
Why?
Public Opinion
1
2008
17
0.160
Why?
Telemedicine
1
2009
40
0.160
Why?
Trust
1
2008
28
0.160
Why?
Diagnosis, Differential
2
1995
855
0.150
Why?
Psychometrics
2
2003
212
0.150
Why?
Risk Reduction Behavior
1
2008
36
0.150
Why?
Perception
1
2008
60
0.150
Why?
Guidelines as Topic
1
2008
87
0.150
Why?
Income
1
2008
65
0.150
Why?
Ethics, Clinical
1
2008
11
0.150
Why?
Thiophenes
1
2008
18
0.150
Why?
Patient Education as Topic
1
2009
207
0.150
Why?
Survival Rate
1
2010
584
0.150
Why?
Emergency Medical Services
1
2009
127
0.150
Why?
Medical Records
2
2003
122
0.150
Why?
Hallucinations
1
2007
12
0.150
Why?
Disorders of Excessive Somnolence
1
2007
8
0.150
Why?
Insurance Claim Reporting
1
2007
5
0.140
Why?
Demography
3
1998
95
0.140
Why?
Epilepsy, Temporal Lobe
1
2007
33
0.140
Why?
Neurosciences
1
2006
7
0.140
Why?
Population Growth
1
2006
6
0.140
Why?
Cognition Disorders
2
2007
262
0.140
Why?
Self Disclosure
1
2007
37
0.140
Why?
Internationality
1
2006
22
0.140
Why?
Population Density
1
2006
14
0.140
Why?
Edema
1
2007
108
0.140
Why?
Nerve Fibers, Myelinated
1
2007
36
0.140
Why?
Peer Review, Research
1
2006
24
0.140
Why?
Physician-Patient Relations
1
2010
333
0.130
Why?
Dizziness
1
2006
13
0.130
Why?
Education, Medical, Graduate
2
2000
106
0.130
Why?
Human Experimentation
1
2006
14
0.130
Why?
Databases, Factual
1
2007
147
0.130
Why?
Toes
1
2005
12
0.130
Why?
Therapeutic Human Experimentation
1
2005
4
0.130
Why?
Health Services Misuse
1
2005
7
0.130
Why?
Polysomnography
1
2005
26
0.130
Why?
Positive-Pressure Respiration
1
2005
26
0.130
Why?
Cholesteatoma
1
2005
2
0.130
Why?
Tetrabenazine
1
2005
5
0.120
Why?
Fluorine Radioisotopes
1
2005
8
0.120
Why?
Dihydroxyphenylalanine
1
2005
22
0.120
Why?
Carbon Radioisotopes
1
2005
75
0.120
Why?
Receptors, Dopamine
1
2005
24
0.120
Why?
Fluorodeoxyglucose F18
1
2005
17
0.120
Why?
Biotransformation
1
2005
113
0.120
Why?
Positron-Emission Tomography
1
2005
35
0.120
Why?
Computer User Training
1
2004
1
0.120
Why?
Hospital Information Systems
1
2004
6
0.120
Why?
Neuropsychological Tests
3
1996
355
0.120
Why?
Hospitals, University
1
2004
72
0.120
Why?
Respiration, Artificial
1
2005
170
0.120
Why?
Follow-Up Studies
3
1998
1757
0.120
Why?
Medical Records Systems, Computerized
1
2004
36
0.110
Why?
Blood-Brain Barrier
1
2005
103
0.110
Why?
Animals
4
2002
15647
0.110
Why?
Logistic Models
1
2006
581
0.110
Why?
Informed Consent
3
2006
77
0.110
Why?
Teaching
1
2004
116
0.110
Why?
Neoplasms
1
2010
701
0.110
Why?
Median Neuropathy
1
2003
3
0.110
Why?
Survival Analysis
1
2005
575
0.110
Why?
Educational Measurement
1
2004
119
0.110
Why?
Program Evaluation
2
1999
170
0.110
Why?
Electrodiagnosis
1
2003
49
0.100
Why?
Urinary Calculi
1
2002
32
0.100
Why?
Breast Diseases
1
2002
28
0.100
Why?
Movement Disorders
3
2004
50
0.100
Why?
Hypotension, Orthostatic
1
2002
11
0.100
Why?
Neopterin
1
2001
5
0.100
Why?
Nerve Degeneration
1
2002
64
0.100
Why?
Expert Testimony
1
2001
14
0.100
Why?
Jurisprudence
1
2001
11
0.100
Why?
Clinical Competence
1
2004
257
0.100
Why?
Cerebral Angiography
2
1998
56
0.090
Why?
Sleep Disorders
1
2002
68
0.090
Why?
Safety
1
2001
99
0.090
Why?
Dyskinesias
1
2000
9
0.090
Why?
Regression Analysis
1
2002
489
0.090
Why?
Job Application
1
2000
3
0.090
Why?
Echocardiography, Transesophageal
1
2000
52
0.090
Why?
Educational Technology
1
1999
4
0.090
Why?
Warfarin
1
2000
46
0.080
Why?
Endarterectomy
1
1999
9
0.080
Why?
CD4 Lymphocyte Count
1
1999
147
0.080
Why?
Enbucrilate
1
1998
3
0.080
Why?
Cerebral Veins
1
1998
8
0.080
Why?
Dura Mater
1
1998
12
0.080
Why?
Tissue Adhesives
1
1998
12
0.080
Why?
Heparin
1
2000
116
0.080
Why?
Bone Cements
1
1998
14
0.080
Why?
Arteriovenous Fistula
1
1998
22
0.080
Why?
Image Enhancement
1
2000
139
0.080
Why?
Brain Edema
1
1998
45
0.080
Why?
Embolization, Therapeutic
1
1998
39
0.080
Why?
AIDS Dementia Complex
1
1999
143
0.080
Why?
Prospective Studies
3
2005
1606
0.070
Why?
Feasibility Studies
2
2004
189
0.070
Why?
Models, Statistical
1
1999
222
0.070
Why?
Motivation
2
2008
148
0.070
Why?
Neurons
1
2005
1053
0.070
Why?
Medical Laboratory Science
1
1996
6
0.070
Why?
Models, Theoretical
1
1998
190
0.070
Why?
Factor Analysis, Statistical
2
2003
56
0.070
Why?
Stereotaxic Techniques
1
1996
32
0.070
Why?
Alzheimer Disease
1
1999
252
0.070
Why?
Subarachnoid Hemorrhage
1
1996
27
0.070
Why?
Cerebral Infarction
1
1996
45
0.070
Why?
Internship and Residency
1
2000
323
0.060
Why?
Evaluation Studies as Topic
1
1996
240
0.060
Why?
Treatment Failure
1
1996
125
0.060
Why?
Placebo Effect
2
2005
36
0.060
Why?
Drug Interactions
1
1995
176
0.060
Why?
Prevalence
2
2006
530
0.060
Why?
Cognition
1
1996
216
0.060
Why?
Spirituality
1
2012
9
0.050
Why?
Chronic Pain
1
2012
9
0.050
Why?
Surgical Procedures, Minimally Invasive
1
2011
30
0.050
Why?
Hand Strength
1
2001
33
0.050
Why?
Monte Carlo Method
1
2011
57
0.050
Why?
Propensity Score
1
2011
6
0.050
Why?
Neoplasm Staging
1
2012
326
0.050
Why?
Observation
1
2011
10
0.050
Why?
Combined Modality Therapy
1
2012
459
0.050
Why?
Caregivers
1
2012
71
0.050
Why?
Microvilli
1
2010
37
0.050
Why?
Video Recording
1
2010
48
0.050
Why?
Body Mass Index
1
2001
207
0.050
Why?
Survivors
1
2012
112
0.040
Why?
Gastrointestinal Hemorrhage
1
2011
84
0.040
Why?
Multicenter Studies as Topic
1
2000
126
0.040
Why?
Health Facility Administration
1
2009
2
0.040
Why?
Ergotamines
1
2009
2
0.040
Why?
Tryptamines
1
2009
2
0.040
Why?
Ketorolac
1
2009
4
0.040
Why?
Federal Government
1
2009
7
0.040
Why?
Forms and Records Control
1
2009
18
0.040
Why?
United States Food and Drug Administration
1
2009
42
0.040
Why?
Stents
1
2010
124
0.040
Why?
Clinical Laboratory Techniques
1
2009
39
0.040
Why?
Menopause
1
2009
40
0.040
Why?
Narcotics
1
2009
43
0.040
Why?
Drug Discovery
1
2009
11
0.040
Why?
Veterans
1
2009
35
0.040
Why?
Extracellular Matrix Proteins
1
1989
74
0.040
Why?
Exons
1
1989
165
0.040
Why?
Introns
1
1989
112
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2009
89
0.040
Why?
Joint Commission on Accreditation of Healthcare Organizations
1
2008
6
0.040
Why?
Chi-Square Distribution
1
2009
320
0.040
Why?
Longitudinal Studies
1
2010
372
0.040
Why?
Mental Disorders
1
2012
301
0.040
Why?
Glycoproteins
1
1989
189
0.040
Why?
Single-Blind Method
1
2008
114
0.040
Why?
Extracellular Matrix
1
1989
155
0.040
Why?
Patient Care Planning
1
2007
63
0.030
Why?
Sex Distribution
1
2007
142
0.030
Why?
Biotechnology
1
2006
18
0.030
Why?
Efficiency, Organizational
1
2006
31
0.030
Why?
Age Distribution
1
2007
201
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2009
247
0.030
Why?
Heart Diseases
1
2007
132
0.030
Why?
Health Care Surveys
1
2007
139
0.030
Why?
Myocardial Infarction
1
2011
630
0.030
Why?
Temporal Lobe
1
2007
110
0.030
Why?
Causality
1
2005
43
0.030
Why?
Brain Tissue Transplantation
1
2005
23
0.030
Why?
Platelet Aggregation Inhibitors
1
2005
57
0.030
Why?
Aspirin
1
2005
58
0.030
Why?
Canada
1
2005
75
0.030
Why?
Voluntary Programs
1
2004
2
0.030
Why?
Sentinel Surveillance
1
2004
2
0.030
Why?
Computer Literacy
1
2004
3
0.030
Why?
Systems Analysis
1
2004
7
0.030
Why?
Drug Tolerance
1
2004
34
0.030
Why?
Staff Development
1
2004
26
0.030
Why?
Socioeconomic Factors
1
2006
364
0.030
Why?
Feedback
1
2004
71
0.030
Why?
Incidence
1
2006
644
0.030
Why?
Activities of Daily Living
1
2006
250
0.030
Why?
Administration, Oral
1
2005
302
0.030
Why?
Stem Cell Transplantation
1
2005
108
0.030
Why?
History, 20th Century
1
2004
232
0.030
Why?
Statistical Distributions
1
2003
8
0.030
Why?
Likelihood Functions
1
2003
52
0.030
Why?
Wrist
1
2003
49
0.030
Why?
Bayes Theorem
1
2003
38
0.030
Why?
Sex Factors
1
2005
561
0.030
Why?
ROC Curve
1
2003
119
0.030
Why?
Hospitals, Teaching
1
2002
79
0.030
Why?
Dose-Response Relationship, Drug
1
2005
1085
0.030
Why?
Electromyography
1
2003
170
0.030
Why?
Neural Conduction
1
2003
139
0.030
Why?
Patient Admission
1
2002
77
0.030
Why?
Reference Values
1
2003
427
0.020
Why?
Family Practice
1
2002
168
0.020
Why?
Emergency Service, Hospital
1
2002
187
0.020
Why?
Technology Assessment, Biomedical
1
2000
21
0.020
Why?
American Medical Association
1
2000
3
0.020
Why?
Education
1
1999
35
0.020
Why?
Health Policy
1
2000
76
0.020
Why?
Cerebral Arteries
1
1998
36
0.020
Why?
Caudate Nucleus
1
1996
22
0.020
Why?
Atrophy
1
1996
61
0.020
Why?
Hippocampus
1
1996
186
0.010
Why?
Child
1
2002
3897
0.010
Why?
Complement Factor B
1
1989
3
0.010
Why?
Single-Strand Specific DNA and RNA Endonucleases
1
1989
4
0.010
Why?
Complement C2
1
1989
6
0.010
Why?
Endonucleases
1
1989
16
0.010
Why?
DNA Restriction Enzymes
1
1989
88
0.010
Why?
von Willebrand Factor
1
1989
59
0.010
Why?
Integrins
1
1989
45
0.010
Why?
Sequence Homology, Nucleic Acid
1
1989
144
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
1989
81
0.010
Why?
Microscopy, Electron
1
1989
374
0.010
Why?
Epidermal Growth Factor
1
1989
106
0.010
Why?
RNA Splicing
1
1989
142
0.010
Why?
Promoter Regions, Genetic
1
1989
534
0.010
Why?
Amino Acid Sequence
1
1989
1198
0.010
Why?
Transcription, Genetic
1
1989
795
0.010
Why?
Base Sequence
1
1989
1681
0.010
Why?
Molecular Sequence Data
1
1989
1993
0.010
Why?

Visualizations


Holloway's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department